SlideShare ist ein Scribd-Unternehmen logo

Macro genics, inc. – product pipeline review – 2012

•Als DOCX, PDF herunterladen•
•
R
Rose088

Aarkstore Enterprise-MacroGenics, Inc. – Product Pipeline Review – 2012

Business
1 von 4
Aarkstore.com announces, The Latest market research report is available in its vast collection: MacroGenics,Inc. – Product PipelineReview – 2012 More about this report You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MacroGenics, Inc. - Product Pipeline Review - 2012” provides data on the MacroGenics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from MacroGenics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - MacroGenics, Inc. - Brief MacroGenics, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MacroGenics, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Table of contents: List of Tables 4 List of Figures 5 MacroGenics, Inc. Snapshot 6 MacroGenics, Inc. Overview 6 Key Information 6 Key Facts 6 MacroGenics, Inc. – Research and Development Overview 7 Key Therapeutic Areas 7 MacroGenics, Inc. – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 MacroGenics, Inc. – Pipeline Products Glance 12 MacroGenics, Inc. – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 MacroGenics, Inc. Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MacroGenics, Inc. – Early Stage Pipeline Products 15 Discovery Products/Combination Treatment Modalities 15 MacroGenics, Inc. – Drug Profiles 16 DART For Autoimmune Disorders 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 DART mAb 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 mAbs 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 MacroGenics, Inc. – Product Pipeline Review – 2012 TopoTarget A/S – Product Pipeline Review – 2012 YM BioSciences Inc. – Product Pipeline Review – 2012 ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 Acucela Inc. – Product Pipeline Review – 2012 Aldagen, Inc. – Product Pipeline Review – 2012 Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com

Empfohlen

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
Rose088
 

Empfohlen

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
Rose088
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012
Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
Rose088
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
Rose088
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
Rose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
Rose088
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
Rose088
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012
Rose088
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
Rose088
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
Ambikabasa
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012
Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Rose088
 

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 

Ähnlich wie Macro genics, inc. – product pipeline review – 2012

Ähnlich wie Macro genics, inc. – product pipeline review – 2012 (18)

United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 

Mehr von Rose088

Mehr von Rose088 (12)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoption
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 

Kürzlich hochgeladen

zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdf
zukhrafshabbir
 
Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)
Alejandro Cremades
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Dubai Multi Commodity Centre
 
PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for Startups
Alejandro Cremades
 
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdfInnomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra
 
WAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdfWAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdf
Western Alaska Minerals Corp.
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Saksham Gupta
 
Toyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & TransformationsToyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & Transformations
Stefan Wolpers
 

Kürzlich hochgeladen (20)

tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)
 
Copyright: What Creators and Users of Art Need to Know
Copyright: What Creators and Users of Art Need to KnowCopyright: What Creators and Users of Art Need to Know
Copyright: What Creators and Users of Art Need to Know
 
A Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob BadgettA Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob Badgett
 
zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)Inside the Black Box of Venture Capital (VC)
Inside the Black Box of Venture Capital (VC)
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrent
 
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
 
wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORI
 
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdfبروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
بروفايل شركة ميار الخليج للاستشارات الهندسية.pdf
 
PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for Startups
 
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdfInnomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
Innomantra Viewpoint - Building Moonshots : May-Jun 2024.pdf
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future world
 
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptxExploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
 
WAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdfWAM Corporate Presentation May 2024_w.pdf
WAM Corporate Presentation May 2024_w.pdf
 
Aptar Closures segment - Corporate Overview-India.pdf
Aptar Closures segment - Corporate Overview-India.pdfAptar Closures segment - Corporate Overview-India.pdf
Aptar Closures segment - Corporate Overview-India.pdf
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
 
Your Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxYour Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptx
 
Potato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdfPotato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdf
 
Toyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & TransformationsToyota Kata Coaching for Agile Teams & Transformations
Toyota Kata Coaching for Agile Teams & Transformations
 

Macro genics, inc. – product pipeline review – 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: MacroGenics,Inc. – Product PipelineReview – 2012 More about this report You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MacroGenics, Inc. - Product Pipeline Review - 2012” provides data on the MacroGenics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from MacroGenics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - MacroGenics, Inc. - Brief MacroGenics, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MacroGenics, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • 2. Table of contents: List of Tables 4 List of Figures 5 MacroGenics, Inc. Snapshot 6 MacroGenics, Inc. Overview 6 Key Information 6 Key Facts 6 MacroGenics, Inc. – Research and Development Overview 7 Key Therapeutic Areas 7 MacroGenics, Inc. – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 MacroGenics, Inc. – Pipeline Products Glance 12 MacroGenics, Inc. – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 MacroGenics, Inc. Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MacroGenics, Inc. – Early Stage Pipeline Products 15 Discovery Products/Combination Treatment Modalities 15 MacroGenics, Inc. – Drug Profiles 16 DART For Autoimmune Disorders 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 DART mAb 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 mAbs 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
  • 3. List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 MacroGenics, Inc. – Product Pipeline Review – 2012 TopoTarget A/S – Product Pipeline Review – 2012 YM BioSciences Inc. – Product Pipeline Review – 2012 ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 Acucela Inc. – Product Pipeline Review – 2012 Aldagen, Inc. – Product Pipeline Review – 2012 Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
  • 4. Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com